Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 152 No. 4950 (2022)

A retrospective analysis of blood culture-negative endocarditis at a tertiary care centre in Switzerland

  • Roman Dähler
  • Silvio D. Brugger
  • Michelle Frank
  • Matthias Greutmann
  • Juri Sromicki
  • Ewerton Marques-Maggio
  • Frank Imkamp
  • Robert Bauernschmitt
  • Thierry Carrel
  • Annelies S. Zinkernagel
  • Barbara Hasse
Cite this as:
Swiss Med Wkly. 2022;152:40016


AIMS OF THE STUDY: Numerous studies from different countries have contributed to an improved understanding of blood culture-negative infective endocarditis. However, little is known about its epidemiology and microbiology in Switzerland. We aimed to assess the epidemiology and microbiology of blood culture-negative endocarditis at the University Hospital Zurich, Switzerland. 

METHODS: We screened all patients hospitalised between 1997 and 2020 with possible or definite endocarditis at our institution. Thereof, we identified all cases with blood culture-negative endocarditis and retrospectively retrieved patient characteristics, microbiological, histopathological, radiographic and surgical data from medical records.

RESULTS: Among 861 patients screened, 66 (7.7%) cases of blood culture-negative endocarditis were identified. Thereof, 31 cases could be microbiologically documented or not documented (n = 30), and in five cases a non-infectious aetiology was confirmed. Endocarditis predominantly affected men (77%) and the left heart (79%); predisposing factors were prosthetic valves (42%), congenital heart disease (35%) and prior endocarditis (14%). The most common reasons for negative blood cultures were antibiotic treatment prior to blood culture sampling (35%), fastidious and slow growing microorganisms (30%) and definite non-infective endocarditis (8%). Coxiella burneti i and Bartonella spp. were the most common fastidious bacteria identified. In addition to serology, identification of causative microorganisms was possible by microbiological and/or histopathological analysis of tissue samples, of which polymerase chain reaction testing (PCR) of the 16S ribosomal RNA proved to be most successful.

CONCLUSIONS: The present study provides a detailed analysis of blood culture-negative endocarditis over a time span of more than 20 years in Zurich, Switzerland. Antibiotic treatment prior to blood collection, and fastidious and slow growing organisms were identified as main reasons for sterile blood cultures. Typical culture-negative bacteria were mainly found by PCR and/or culture of tissue samples.


  1. Talha KM, Baddour LM, Thornhill MH, Arshad V, Tariq W, Tleyjeh IM, et al. Escalating incidence of infective endocarditis in Europe in the 21st century. Open Heart. 2021 Oct;8(2):e001846. DOI:
  2. Hubers SA, DeSimone DC, Gersh BJ, Anavekar NS. Infective Endocarditis: A Contemporary Review. Mayo Clin Proc. 2020 May;95(5):982–97. DOI:
  3. Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG Jr. Infective endocarditis. Nat Rev Dis Primers. 2016 Sep;2(1):16059. DOI:
  4. Habib G, et al. 2015 ESC Guidelines for the management of infective endocarditis, European Heart Journal, vol. 36, no. 44. Oxford University Press, pp. 3075–3123, 21-Nov-2015, doi: DOI:
  5. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000 Apr;30(4):633–8. DOI:
  6. Houpikian P, Raoult D. Diagnostic methods. Current best practices and guidelines for identification of difficult-to-culture pathogens in infective endocarditis. Cardiol Clin. 2003 May;21(2):207–17. DOI:
  7. Didier Raoult P. MD and M. Daniel J Sexton, Culture-negative endocarditis: Epidemiology, microbiology, and diagnosis - UpToDate, 2019. Online]. Available from: Accessed: 27-Oct-2020].
  8. C. Selton-Suty et al., Preeminence of staphylococcus aureus in infective endocarditis: A 1-year population-based survey, Clinical Infectious Diseases, vol. 54, no. 9. Clin Infect Dis, pp. 1230–1239, 01-May-2012, doi: DOI:
  9. Cecchi E, Forno D, Imazio M, Migliardi A, Gnavi R, Dal Conte I, et al.; Piemonte Infective Endocarditis Study Group. New trends in the epidemiological and clinical features of infective endocarditis: results of a multicenter prospective study. Ital Heart J. 2004 Apr;5(4):249–56.
  10. Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P, et al. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992-2001. Int J Cardiol. 2005 Feb;98(2):253–60. DOI:
  11. Watt G, Lacroix A, Pachirat O, Baggett HC, Raoult D, Fournier PE, et al. Prospective comparison of infective endocarditis in Khon Kaen, Thailand and Rennes, France. Am J Trop Med Hyg. 2015 Apr;92(4):871–4. DOI:
  12. Østergaard L, Voldstedlund M, Bruun NE, Bundgaard H, Iversen K, Køber N, et al. Temporal Changes, Patient Characteristics, and Mortality, According to Microbiological Cause of Infective Endocarditis: A Nationwide Study. J Am Heart Assoc. 2022 Aug;11(16):e025801. DOI:
  13. Benslimani A, Fenollar F, Lepidi H, Raoult D. Bacterial zoonoses and infective endocarditis, Algeria. Emerg Infect Dis. 2005 Feb;11(2):216–24. DOI:
  14. D. O. Mayer and B. Hasse, Gefäß(endo)protheseninfektionen: Erfahrungen und Lehren aus 8 Jahren prospektiver Begleitung der VASGRA-Kohorte am Universitätsspital Zürich, Gefässchirurgie 2020 258, vol. 25, no. 8, pp. 621–631, Nov. 2020, doi: DOI:
  15. Katsouli A, Massad MG. Current issues in the diagnosis and management of blood culture-negative infective and non-infective endocarditis. Ann Thorac Surg. 2013 Apr;95(4):1467–74. DOI:
  16. B. Hasse et al., International Society of Cardiovascular Infectious Diseases Guidelines for the Diagnosis, Treatment and Prevention of Disseminated Mycobacterium chimaera Infection Following Cardiac Surgery with Cardiopulmonary Bypass, Journal of Hospital Infection, vol. 104, no. 2. W.B. Saunders Ltd, pp. 214–235, 01-Feb-2020, doi: DOI:
  17. Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010 Jul;51(2):131–40. DOI:
  18. Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briançon S, Leport C, et al. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis. 1995 Mar;20(3):501–6. DOI:
  19. Houpikian P, Raoult D. Blood culture-negative endocarditis in a reference center: etiologic diagnosis of 348 cases. Medicine (Baltimore). 2005 May;84(3):162–73. DOI:
  20. S. L. Sharara, R. Tayyar, Z. A. Kanafani, and S. S. Kanj, HACEK endocarditis: a review, Expert Review of Anti-Infective Therapy, vol. 14, no. 6. Taylor and Francis Ltd, pp. 539–545, 02-Jun-2016, doi: DOI:
  21. Tattevin P, Watt G, Revest M, Arvieux C, Fournier PE. Update on blood culture-negative endocarditis. Med Mal Infect. 2015;45(1-2):1–8. DOI:
  22. Fenollar F, Célard M, Lagier JC, Lepidi H, Fournier PE, Raoult D. Tropheryma whipplei endocarditis. Emerg Infect Dis. 2013 Nov;19(11):1721–30. DOI:
  23. Sax H, Bloemberg G, Hasse B, Sommerstein R, Kohler P, Achermann Y, et al. Prolonged outbreak of mycobacterium chimaera infection after open-chest heart surgery. Clin Infect Dis. 2015 Jul;61(1):67–75. DOI:
  24. van Ingen J, Kohl TA, Kranzer K, Hasse B, Keller PM, Katarzyna Szafrańska A, et al. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. Lancet Infect Dis. 2017 Oct;17(10):1033–41. DOI:
  25. Sommerstein R, Rüegg C, Kohler P, Bloemberg G, Kuster SP, Sax H. Transmission of Mycobacterium chimaera from heater-cooler units during cardiac surgery despite an ultraclean air ventilation system. Emerg Infect Dis. 2016 Jun;22(6):1008–13. DOI:
  26. Kohler P, Kuster SP, Bloemberg G, Schulthess B, Frank M, Tanner FC, et al. Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. Eur Heart J. 2015 Oct;36(40):2745–53. DOI:
  27. I. Steiner, Nonbacterial thrombotic endocarditis--a study of 171 case reports (Article in Czech), Ces. Patol., vol. 29, no. 2, 1993.
  28. Asopa S, Patel A, Khan OA, Sharma R, Ohri SK. Non-bacterial thrombotic endocarditis. Eur J Cardiothorac Surg. 2007 Nov;32(5):696–701. DOI:
  29. Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart. 2003 Mar;89(3):258–62. DOI:
  30. Brandão TJ, Januario-da-Silva CA, Correia MG, Zappa M, Abrantes JA, Dantas AM, et al. Histopathology of valves in infective endocarditis, diagnostic criteria and treatment considerations. Infection. 2017 Apr;45(2):199–207. DOI:
  31. R. M. Liesman, B. S. Pritt, J. J. Maleszewski, and R. Patela, Laboratory diagnosis of infective endocarditis, Journal of Clinical Microbiology, vol. 55, no. 9. American Society for Microbiology, pp. 2599–2608, 01-Sep-2017, doi: DOI:
  32. Lamas CC, Fournier PE, Zappa M, Brandão TJ, Januário-da-Silva CA, Correia MG, et al. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases. Infection. 2016 Aug;44(4):459–66. DOI:
  33. Morris AJ, Drinkovic D, Pottumarthy S, Strickett MG, MacCulloch D, Lambie N, et al. Gram stain, culture, and histopathological examination findings for heart valves removed because of infective endocarditis. Clin Infect Dis. 2003 Mar;36(6):697–704. DOI:
  34. Harris KA, Yam T, Jalili S, Williams OM, Alshafi K, Gouliouris T, et al. Service evaluation to establish the sensitivity, specificity and additional value of broad-range 16S rDNA PCR for the diagnosis of infective endocarditis from resected endocardial material in patients from eight UK and Ireland hospitals. Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):2061–6. DOI:
  35. Godfrey R, Curtis S, Schilling WH, James PR. Blood culture negative endocarditis in the modern era of 16S rRNA sequencing. Clin Med (Lond). 2020 Jul;20(4):412–6. DOI:
  36. Al Mohajer M, Darouiche RO. Staphylococcus aureus bacteriuria: Source, clinical relevance, and management. Curr Infect Dis Rep. 2012 Dec;14(6):601–6. DOI:
  37. Lafon T, Hernandez Padilla AC, Baisse A, Lavaud L, Goudelin M, Barraud O, et al. Community-acquired Staphylococcus aureus bacteriuria: a warning microbiological marker for infective endocarditis? BMC Infect Dis. 2019 Jun;19(1):504. DOI:

Most read articles by the same author(s)

1 2 > >>